Articular cartilage disorder
diseaseOn this page
Also known as articular cartilage disorder involving ankle and footarticular cartilage disorder involving forearmarticular cartilage disorder involving handarticular cartilage disorder involving multiple sitesarticular cartilage disorder involving pelvic region and thigharticular cartilage disorder involving shoulder regionarticular cartilage disorder involving upper armarticular cartilage disorder of ankle and/or footarticular cartilage disorder of forearmarticular cartilage disorder of handarticular cartilage disorder of multiple sitesarticular cartilage disorder of shoulder regionarticular cartilage disorder of the pelvic region and thigharticular cartilage disorder of upper armarticular cartilage of joint diseasearticular cartilage of joint disease or disorderdisease of articular cartilage of jointdisease or disorder of articular cartilage of jointdisorder of articular cartilage of joint
Summary
Articular cartilage disorder (MONDO:0003816) is a disease with 1 GWAS associations across 8 studies and 4 clinical trials. A subtype of arthropathy — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- GWAS associations: 1
- Clinical trials: 4
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | articular cartilage disorder |
| Mondo ID | MONDO:0003816 |
| DOID | DOID:6227 |
| SNOMED CT | 53417006 |
| UMLS | C0158073 |
| MedGen | 510440 |
| Anatomy (UBERON) | UBERON:0010996 |
| Is cancer (heuristic) | no |
Also known as: articular cartilage disorder · articular cartilage disorder involving ankle and foot · articular cartilage disorder involving forearm · articular cartilage disorder involving hand · articular cartilage disorder involving multiple sites · articular cartilage disorder involving pelvic region and thigh · articular cartilage disorder involving shoulder region · articular cartilage disorder involving upper arm · articular cartilage disorder of ankle and/or foot · articular cartilage disorder of forearm · articular cartilage disorder of hand · articular cartilage disorder of multiple sites · articular cartilage disorder of shoulder region · articular cartilage disorder of the pelvic region and thigh · articular cartilage disorder of upper arm · articular cartilage of joint disease · articular cartilage of joint disease or disorder · disease of articular cartilage of joint · disease or disorder of articular cartilage of joint · disorder of articular cartilage of joint
Data availability: 1 GWAS association (8 studies).
Disease family
This is a subtype of arthropathy. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › skeletal system disorder › arthropathy › articular cartilage disorder
Related subtypes (23): transient arthropathy, synovial plica syndrome, hypermobility syndrome, Tietze syndrome, neurogenic arthropathy, Behcet syndrome arthropathy, ankylosis, bursitis, synovium neoplasm, hydrarthrosis, hemarthrosis, tenosynovitis, ganglion or cyst of synovium/tendon/bursa, spondyloarthropathy, temporomandibular joint disorder, arthritic joint disease, de Quervain disease, frozen shoulder, patellofemoral pain syndrome, secondary hypertrophic osteoarthropathy, shoulder impingement syndrome, crystal arthropathy, vertebral joint disorder
Subtypes (1): chondromalacia
Genetics & variants
GWAS landscape
1 GWAS associations across 8 studies. Top hits map to 0 distinct genes (as reported by GWAS).
Top associations by p-value
| rsID | p-value | Gene | Risk allele | Odds ratio |
|---|---|---|---|---|
| rs1490626752 | 1e-08 | NA - FAM230C | ? |
Top studies (by case count)
| Study | Lead author | Year | Cases | Controls | Title |
|---|---|---|---|---|---|
| GCST90080449 | Backman JD | 2021 | 1,157 | 386,756 | Exome sequencing and analysis of 454,787 UK Biobank participants. |
| GCST90084435 | Backman JD | 2021 | 1,157 | 386,756 | Exome sequencing and analysis of 454,787 UK Biobank participants. |
| GCST90080448 | Backman JD | 2021 | 605 | 387,325 | Exome sequencing and analysis of 454,787 UK Biobank participants. |
| GCST90084434 | Backman JD | 2021 | 605 | 387,325 | Exome sequencing and analysis of 454,787 UK Biobank participants. |
| GCST90436735 | Zhou W | 2018 | 500 | 402,633 | Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. |
| GCST90044598 | Jiang L | 2021 | 484 | 455,864 | A generalized linear mixed model association tool for biobank-scale data. |
| GCST90482437 | Verma A | 2024 | 419 | 448,990 | Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. |
| GCST90651502 | Liu TY | 2025 | 122 | 235,669 | Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population. |
Variant details and genetic-evidence tiers
Tier distribution (top 50 variants)
| Tier | Variants |
|---|---|
| Tier 1: coding | 0 |
| Tier 2: splice/UTR | 0 |
| Tier 3: regulatory | 0 |
| Tier 4: intronic/intergenic | 1 |
MAF distribution
| Bucket | Variants |
|---|---|
| common (>=0.05) | 0 |
| low_freq (0.01-0.05) | 0 |
| rare (<0.01) | 0 |
| unknown | 1 |
Functional consequences
| Consequence | Count |
|---|---|
| intergenic_variant | 1 |
Top variants
| rsID | Chr | Pos | Alleles | MAF | Consequence | Gene | p-value | Tier |
|---|---|---|---|---|---|---|---|---|
| rs1490626752 | 13 | 16358301 | G>A,C,T | intergenic_variant | NA - FAM230C | 1e-08 | Tier 4: intronic/intergenic |
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 4.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 3 |
| PHASE3 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT01400607 | PHASE3 | TERMINATED | Neocartilage Implant to Treat Cartilage Lesions of the Knee |
| NCT01410136 | Not specified | TERMINATED | Chondrofix Osteochondral Allograft Prospective Study |
| NCT01690689 | Not specified | COMPLETED | Investigation of a Customized Femoral Resurfacing Implant |
| NCT05424848 | Not specified | COMPLETED | Femoral Cartilage Thickness in Parkinson’s Disease |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.